Gables Capital Management’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-542
| Closed | -$2K | – | 349 |
|
|
2021
Q3 | $2K | Hold |
542
| – | – | ﹤0.01% | 334 |
|
|
2021
Q2 | $2K | Hold |
542
| – | – | ﹤0.01% | 333 |
|
|
2021
Q1 | $5K | Hold |
542
| – | – | ﹤0.01% | 347 |
|
|
2020
Q4 | $5K | Hold |
542
| – | – | ﹤0.01% | 330 |
|
|
2020
Q3 | $2K | Buy |
542
+417
| +334% | +$1.54K | ﹤0.01% | 350 |
|
|
2020
Q2 | $1K | Hold |
125
| – | – | ﹤0.01% | 345 |
|
|
2020
Q1 | $0 | Hold |
125
| – | – | ﹤0.01% | 417 |
|
|
2019
Q4 | $1K | Hold |
125
| – | – | ﹤0.01% | 339 |
|
|
2019
Q3 | $0 | Hold |
125
| – | – | ﹤0.01% | 356 |
|
|
2019
Q2 | $1K | Hold |
125
| – | – | ﹤0.01% | 329 |
|
|
2019
Q1 | $1K | Hold |
125
| – | – | ﹤0.01% | 339 |
|
|
2018
Q4 | $0 | Buy |
+125
| New | – | ﹤0.01% | 372 |
|